Cynaps Logo
FeaturesResearchBlogAbout Us

Research

Our research teams study the reliability, safety, and real-world impact of AI systems in healthcare, with a focus on India’s unique healthcare landscape. By examining how these models operate, how they make decisions, and how they affect patients and clinicians, we aim to ensure that artificial intelligence strengthens healthcare delivery across diverse communities. Our goal is to help AI support doctors, improve access to care, and create equitable health outcomes as these technologies become more widely used.

Project GEM: De Novo Drug Design

GEM ResearchMar 5, 2026

An AI driven platform designed for generating synthetic and plant based molecules. It features built in intelligence for designing, visualizing, and simulating new entities, accelerating the early stages of drug discovery.

InterprobalityFeb 12, 2026

Unifying EMR Data Streams

Can autonomous agents reliably reconcile conflicting data from multiple health information systems? This research demonstrates a novel approach to zero-loss interoperability in acute care settings.

Pharmacognosy AIJan 28, 2026

Network Pharmacology of Polyherbal Formulations

Tracing the synergistic effects of natural pharmacognostic compounds through modern machine learning, uncovering new therapeutic pathways for chronic metabolic conditions.

Cynaps Logo

Clinical Workflow Elevated.

© 2026 Cynaps Intelligence.
High Fidelity Clinical Data.
A product of NBALL Technologies India Private Limited.

Products

  • Features
  • Pharmacy
  • Labs
  • Pricing
  • Use Cases
  • Documentation

Company

  • About Us
  • Careers
  • Research
  • Blog

Help and security

  • Support center
  • Security & Compliance

Terms and policies

  • Privacy Policy
  • Terms of service
  • Refund Policy
  • AI Usage Policy
  • Cookie Policy
Medical Disclaimer

Cynaps Intelligence is engineered for licensed healthcare professionals. It serves as a clinical decision support tool and does not provide diagnostic or therapeutic advice directly to patients. Always triangulate clinical decisions with institutional protocols and verify dosing with current formulary data.